Kearny Financial holds Annual Meeting; key votes reported
Kearny Financial Corp. reports results from its Annual Meeting, including director elections and auditor appointments, impacting shareholder engagement.
Plumas Bancorp unveils new investor presentation
Plumas Bancorp has announced a new investor presentation, highlighting its commitment to transparency and engagement with stakeholders.
Nevada Canyon Gold Corp. updates on Lapon Canyon Project
Nevada Canyon Gold Corp. shares insights on the Lapon Canyon Project following recent drill results, impacting the gold and silver ores sector.
Aptera Motors extends Interim CFO Tom DaPolito's contract
Aptera Motors Corp has extended the contract of Interim CFO Tom DaPolito through 2027, signaling a commitment to stable financial leadership.
Tempest Therapeutics holds special meeting, adjourns for vote
Tempest Therapeutics' special meeting to amend voting requirements adjourns without approval, with a follow-up meeting scheduled for November 12, 2026.
Worthington Steel Issues Statement Ahead of Kloeckner EGM
Worthington Steel addresses Kloeckner & Co's upcoming extraordinary general meeting, detailing the potential impact of a key vote.
Roivant Sciences reports positive Phase 3 results for brepocitinib
Roivant Sciences announces positive Phase 3 results for brepocitinib, a potential treatment for non-infectious uveitis, signaling a breakthrough in the pharmaceutical industry.
Genprex highlights TUSC2 gene findings in new research release
Genprex, Inc. reveals new research on TUSC2 gene's role in brain aging, potentially impacting cancer therapies and neurodegenerative disease understanding.
U.S. Government Invests $250 Million in Nova Minerals Project
Nova Minerals Corp secures $250 million from the U.S. government to support its critical minerals processing hub in Alaska, enhancing its operational capabilities.
Labcorp Declares $0.72 Quarterly Dividend for Shareholders
Labcorp Holdings Inc. announces a quarterly cash dividend of $0.72 per share, payable on December 11, 2026, reflecting its strong performance in medical laboratories.
Amalgamated Financial Corp. Declares Quarterly Dividend
Amalgamated Financial Corp. announces a quarterly dividend of $0.17 per share, payable on November 19, 2026, reflecting its commitment to shareholder returns.
Old Second Bancorp declares cash dividend of $0.08 per share
Old Second Bancorp Inc. announces a cash dividend of $0.08 per share, reflecting financial stability and enhancing shareholder value.
Oncolytics Biotech reveals REO 033 trial details for ESMO 2026
Oncolytics Biotech announces REO 033 trial details to be presented at ESMO 2026, showcasing potential advancements in colorectal cancer treatment.
Microbot Medical sets annual meeting, announces patent wins
Microbot Medical Inc. announces its annual meeting date and new patent approvals, signaling growth in the surgical instruments sector.
Planet Green Holdings reports unusual trading activity
Planet Green Holdings Corp. addresses unusual trading activity in its stock, raising questions about market conditions in the canned and preserved food sector.
Blue Owl Capital Corp II Declares $0.62 Per Share Distribution
Blue Owl Capital Corp II announces a $0.62 per share capital distribution, exceeding its previous targets and showcasing strong portfolio management.
Arcus Biosciences Presents New Data on Casdatifan for ccRCC
Arcus Biosciences announces new data from its ARC-20 study on casdatifan, showing promising results for treating clear cell renal cell carcinoma.
StubHub appoints Andrew Raab to Board of Directors
StubHub Holdings, Inc. enhances its Board with Andrew Raab's appointment, bringing valuable capital markets experience to the team.
Lipocine Inc. Updates Corporate Presentation for Investors
Lipocine Inc. updates its corporate presentation, enhancing investor engagement and transparency in the pharmaceutical preparations industry.
Odyssey Therapeutics Reports Positive Phase 2a Results for OD-001
Odyssey Therapeutics announces encouraging Phase 2a trial results for OD-001, enhancing its standing in the biological products industry.